Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes.
about
A kinetic study of the polymorphic transformation of nimodipine and indomethacin during high shear granulation.Effects of Surface Composition on the Aerosolisation and Dissolution of Inhaled Antibiotic Combination Powders Consisting of Colistin and RifampicinProcess analytical applications of Raman spectroscopy.Excipient selection can significantly affect solid-state phase transformation in formulation during wet granulationAnalysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy.Spherical crystallization of drugs.The solid-state continuum: a perspective on the interrelationships between different solid-state forms in drug substance and drug product.A proposal for a drug product Manufacturing Classification System (MCS) for oral solid dosage forms.Understanding pharmaceutical polymorphic transformations I: influence of process variables and storage conditions.Integration of active pharmaceutical ingredient solid form selection and particle engineering into drug product design.Mesoporous silica formulation strategies for drug dissolution enhancement: a review.Moisture Sorption-desorption Characteristics and the Corresponding Thermodynamic Properties of Carvedilol PhosphateInfluence of drug load on dissolution behavior of tablets containing a poorly water-soluble drug: estimation of the percolation threshold.Towards medicinal mechanochemistry: evolution of milling from pharmaceutical solid form screening to the synthesis of active pharmaceutical ingredients (APIs).Solid-State Forms of β-Resorcylic Acid: How Exhaustive Should a Polymorph Screen Be?Stoichiometric and Non-Stoichiometric Hydrates of Brucine.Pellet manufacturing by extrusion-spheronization using process analytical technology.Quantitative measurement of indomethacin crystallinity in indomethacin-silica gel binary system using differential scanning calorimetry and X-ray powder diffractometry.Influence of processing-induced phase transformations on the dissolution of theophylline tablets.Solid-State Characterization and Interconversion of Recrystallized Amodiaquine Dihydrochloride in Aliphatic Monohydric Alcohols.Mechanically induced amorphization of drugs: a study of the thermal behavior of cryomilled compounds.Influence of formulation and processing factors on stability of levothyroxine sodium pentahydrateThe influence of pressure on the intrinsic dissolution rate of amorphous indomethacin.Eutectics as improved pharmaceutical materials: design, properties and characterization.Effect of processing on Celecoxib and its solvates.New Insights into Solid Form Stability and Hydrate Formation: o-Phenanthroline HCl and Neocuproine HCl.Droplet-Templated Antisolvent Spherical Crystallization of Hydrophilic and Hydrophobic Drugs with an in situ Formed Binder.Characterization of Crystalline Phase‐Transformations in Theophylline by Time‐Domain Terahertz SpectroscopyPrediction of the Mechanical Behaviour of Crystalline Solids
P2860
Q35100389-1D8C547A-116A-4AA8-B493-C9B5EA934A2DQ36653925-AE0706D4-78A5-45FF-9D2B-1296BA86681EQ36725305-4EDC7F25-3743-4FE5-9254-ABD685110B3EQ37360836-61BF6F53-AD86-4588-9A84-6760CDD76C20Q37585656-85AD13AE-77ED-45B2-8002-14D547DF259DQ37999585-685D78DF-8447-403A-AD53-25D858405D0BQ38239948-80717D35-9331-4969-84BE-3C6084E16C61Q38243872-8C473EE8-338E-484C-B98E-F0A77AD07560Q38270691-EF4AFDE0-4468-49C8-AC6E-C3E609C5D203Q38353795-A16FB38B-3C2A-4FCF-AC7D-9195786B4431Q38628433-737641FA-02AE-477F-9614-EBA97E53C90AQ38741902-10DA65E4-8418-42FF-9F44-6496290A80D4Q38842789-A910AB45-1B2B-43CC-A5EE-175563DDB32DQ38866596-371DBBCC-2D3E-4294-8101-9D945CF4C388Q41625614-3BD49C89-B594-457F-815E-8A4B2C366E11Q41671576-4EBFC384-3190-4A29-B883-72B7BFD0B1D7Q41818604-55D56E6B-D61C-481B-8284-911AE1366427Q41840018-760CE0B6-1053-410C-8EE0-AB49985E5A69Q41981346-2E54FFE9-A50F-47B9-AABC-9E98E896EFCCQ41987417-D08A950E-C5D9-4FC5-86E3-770E25E8D702Q41988275-96EF4FE2-6DAE-4BAA-A7A9-482883C7487BQ42734626-BBF9E2B2-BC88-4927-B538-7896195E8CEFQ42936252-A4B21019-614A-4479-BE56-3E6CDD8273D2Q44122680-B2D52D84-CC07-44FE-9B96-693E29863469Q45174664-940E3258-8E2B-43B6-8F5E-F3D3FC3D52BDQ47303603-01A5FE0D-DEDF-448A-9E3A-4CB6CD776053Q47618573-EFAAFEF6-5B15-4C8F-B5EB-EE62192649F9Q56829163-53E6A08C-DA6E-414C-9603-E68B726F7A36Q57617888-0B381B43-E855-4F68-BAA9-AA8BD1E3B05B
P2860
Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Theoretical approaches to phys ...... uring manufacturing processes.
@ast
Theoretical approaches to phys ...... uring manufacturing processes.
@en
Theoretical approaches to phys ...... uring manufacturing processes.
@nl
type
label
Theoretical approaches to phys ...... uring manufacturing processes.
@ast
Theoretical approaches to phys ...... uring manufacturing processes.
@en
Theoretical approaches to phys ...... uring manufacturing processes.
@nl
prefLabel
Theoretical approaches to phys ...... uring manufacturing processes.
@ast
Theoretical approaches to phys ...... uring manufacturing processes.
@en
Theoretical approaches to phys ...... uring manufacturing processes.
@nl
P2093
P1476
Theoretical approaches to phys ...... during manufacturing processes
@en
P2093
C J Eckhardt
J G Stowell
K R Morris
P304
P356
10.1016/S0169-409X(01)00100-4
P407
P577
2001-05-01T00:00:00Z